ES2156393T3 - Peptidos del complejo de tlp de carcinoma urogenital y sus anticuerpos. - Google Patents

Peptidos del complejo de tlp de carcinoma urogenital y sus anticuerpos.

Info

Publication number
ES2156393T3
ES2156393T3 ES97932002T ES97932002T ES2156393T3 ES 2156393 T3 ES2156393 T3 ES 2156393T3 ES 97932002 T ES97932002 T ES 97932002T ES 97932002 T ES97932002 T ES 97932002T ES 2156393 T3 ES2156393 T3 ES 2156393T3
Authority
ES
Spain
Prior art keywords
peptides
antibodies
urogenital
tlp
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97932002T
Other languages
English (en)
Inventor
Giulio Tarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unihart Corp
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Application granted granted Critical
Publication of ES2156393T3 publication Critical patent/ES2156393T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PEPTIDO QUE COMPRENDE UN EPITOPO ESPECIFICO DE TLP (PROTEINAS LIBERADAS POR TUMORES) DE CARCINOMA UROGENITAL, QUE COMPRENDEN A SU VEZ LA SECUENCIA DE AMINOACIDOS GLIPROPROGLUVALGLNASNALAASN. LA INVENCION ESTA RELACIONADA ASIMISMO CON REACTIVOS QUE PERMITEN DETECTAR ESTAS TLP UROGENITALES Y CON COMPOSICIONES FARMACEUTICAS.
ES97932002T 1996-07-10 1997-07-02 Peptidos del complejo de tlp de carcinoma urogenital y sus anticuerpos. Expired - Lifetime ES2156393T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000496A IT1284870B1 (it) 1996-07-10 1996-07-10 Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi

Publications (1)

Publication Number Publication Date
ES2156393T3 true ES2156393T3 (es) 2001-06-16

Family

ID=11404336

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97932002T Expired - Lifetime ES2156393T3 (es) 1996-07-10 1997-07-02 Peptidos del complejo de tlp de carcinoma urogenital y sus anticuerpos.

Country Status (16)

Country Link
US (3) US6222010B1 (es)
EP (1) EP0851872B1 (es)
CN (1) CN1136230C (es)
AT (1) ATE200678T1 (es)
AU (1) AU716721B2 (es)
CA (1) CA2234151C (es)
DE (1) DE69704606T2 (es)
DK (1) DK0851872T3 (es)
ES (1) ES2156393T3 (es)
GR (1) GR3036057T3 (es)
IT (1) IT1284870B1 (es)
NO (1) NO982227D0 (es)
PT (1) PT851872E (es)
RU (1) RU2203679C2 (es)
SK (1) SK47098A3 (es)
WO (1) WO1998001462A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284870B1 (it) 1996-07-10 1998-05-22 Ist Farmacoterapico It Spa Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
DE10001717C1 (de) * 2000-01-18 2001-04-26 Xcellsis Gmbh Brennstoffzellensystem
ITMI20011380A1 (it) * 2001-06-29 2002-12-29 Unihart Corp Antigene tlp e sue applicazioni diagnostiche
CN101712946B (zh) * 2009-09-27 2013-02-27 南通大学附属医院 构建生殖结节器官培养尿道体外发育模型的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
IT1284870B1 (it) 1996-07-10 1998-05-22 Ist Farmacoterapico It Spa Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi

Also Published As

Publication number Publication date
PT851872E (pt) 2001-08-30
CA2234151C (en) 2004-02-03
CA2234151A1 (en) 1998-01-15
ITRM960496A1 (it) 1998-01-10
US20030170750A1 (en) 2003-09-11
EP0851872A3 (en) 1998-10-14
WO1998001462A2 (en) 1998-01-15
NO982227L (no) 1998-05-15
RU2203679C2 (ru) 2003-05-10
WO1998001462A3 (en) 1998-08-06
US6222010B1 (en) 2001-04-24
DE69704606D1 (de) 2001-05-23
CN1136230C (zh) 2004-01-28
DE69704606T2 (de) 2001-11-08
DK0851872T3 (da) 2001-06-18
IT1284870B1 (it) 1998-05-22
SK47098A3 (en) 1999-02-11
EP0851872A2 (en) 1998-07-08
CN1205012A (zh) 1999-01-13
GR3036057T3 (en) 2001-09-28
NO982227D0 (no) 1998-05-15
AU3557297A (en) 1998-02-02
AU716721B2 (en) 2000-03-02
ATE200678T1 (de) 2001-05-15
EP0851872B1 (en) 2001-04-18
US6664378B1 (en) 2003-12-16
ITRM960496A0 (es) 1996-07-10

Similar Documents

Publication Publication Date Title
DK0948518T3 (da) Isoleret nucleinsyremolekyle kodende for et cancer-associeret antigen, selve antigenet samt anvendelser deraf
PT891428E (pt) Sub-unidade catalitica fosfatidilinositol 3-cinase p110 delta
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
CO5050400A1 (es) Proteina de chlamydia, secuencia de genes y anticuerpos para ello
ES2173082T3 (es) Vectores retrovirales que contienen sitios de entrada del ribosoma internos.
HUP0200400A2 (hu) Fehérjék izolálása és elemzése
MY120693A (en) Human bikunin
ATE317441T1 (de) Cathepsin-02-protease
DK1084146T3 (da) Hybridprotein til inhibering af degranuleringen af mastocyter og anvendelse deraf
HN2000000203A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
FR2772721B3 (fr) Bouteille ayant une gorge annulaire
DK366483A (da) Gen, dna-transfervektor eller underenhed heraf, der koder for human preprorelaxin eller en underenhed deraf, fremgangsmaade til fremstilling af samme samt fremgangsmaade til fremstilling af human preprorelaxin eller en underenhed deraf
ES2156393T3 (es) Peptidos del complejo de tlp de carcinoma urogenital y sus anticuerpos.
DK0470980T3 (da) Syntetiske peptider til en HIV-1-vaccine
ATE180489T1 (de) Für leberzellkarzinom spezifisches onkogen
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
DK112797A (da) Lufthavn og drift af denne.
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
BR0215248A (pt) Reagente a base de peptìdeo modular
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
DK0728015T3 (da) Kombinatoriske polypeptidantigener
WO2002055536A3 (en) Regulation of target protein activity through modifier proteins
DE69224631D1 (de) Bindendes protein fixierungstest.
ES2067501T3 (es) Antigeno recombinante de treponema hyodysenteriae y sus usos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 851872

Country of ref document: ES